LabGenius is a pioneering brand that combines human and machine intelligence to accelerate the discovery of advanced medicines. Using cutting-edge technology platforms such as machine learning, synthetic biology, and laboratory automation, LabGenius is at the forefront of finding the next generation of antibody therapeutics. Through their smart robotic platform, EVA™, LabGenius designs, conducts, and learns from its own experiments, radically improving the drug discovery process and making the generation of advanced antibody therapeutics faster.

With their unique approach called active learning, LabGenius intelligently navigates the design space, increasing the likelihood of finding high-performing antibodies. The powerful antibodies discovered by LabGenius often contain non-intuitive features that wouldn't have been found using conventional methods. Currently, LabGenius focuses on the rapid discovery and optimization of novel therapeutic antibodies for cancer and inflammatory diseases.

They also offer partnerships for the discovery and optimization of antibody therapeutics, providing access to their ML-driven protein engineering platform, EVA™. Join LabGenius in their mission to revolutionize medicine and contribute to groundbreaking scientific breakthroughs